Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Cited by (1,001)

Items 401–500 of 1,001

1. Clinical characteristics and risk factors for in‐hospital mortality of lung cancer patients with COVID ‐19: A multicenter, retrospective, cohort study
   Lei Nie, Kai Dai, Jiang Wu, Xia Zhou, Junjun Hu, Chao Zhang, Yan Zhan, Yu Song, Wen Fan, Zhimin Hu et al. · 2020 · Thoracic Cancer
2. Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era
   Gary H. Lyman, Nicole M. Kuderer, Matti Aapro · 2021 · Frontiers in Oncology
3. Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19
   Carolina García‐Vidal, Pedro Puerta‐Alcalde, Aina Mateu, Genoveva Cuesta, Fernanda Salazar Meira, Carlos Lopera, Patricia Monzó, Marta Santos Bravo, Gerard Dueñas, Mariana Chumbita et al. · 2022 · Haematologica
4. Cancer care during and after the pandemic
   Richard David Neal, Larissa Nekhlyudov, Pete Wheatstone, Bogda Koczwara · 2020 · BMJ
5. Thyroid cancer in the Era of COVID-19
   Anabella Smulever, Erika Abelleira, Fernanda Bueno, Fabián Pitoia · 2020 · Endocrine
6. Oncology and COVID-19
   Mary Lenora Disis · 2020 · JAMA
7. Virtual Cancer Care During the COVID-19 Pandemic and Beyond: A Call for Evaluation
   Oren Hannun Levine, Michael Hugh McGillion, Mark N. Levine · 2020 · JMIR Cancer
8. Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420)
   Aline Bobato Lara Gongora, Gustavo Werutsky, Denis L. Fontes Jardim, Angélica Nogueira‐Rodrigues, Carlos H. Barrios, Clarissa Mathias, Fernando Cotait Maluf, Rachel P. Riechelmann, Maurício Fraga, Henry Gomes et al. · 2021 · JCO Global Oncology
9. Radiotherapy based management during Covid-19 pandemic – A systematic review of presented consensus and guidelines
   Zahra Siavashpour, Neda Goharpey, Mosayyeb Mobasheri · 2021 · Critical Reviews in Oncology/Hematology
10. Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection
    Annoor Awadasseid, Qiang Yin, Yanling Wu, Wen Zhang · 2021 · Biomedicine & Pharmacotherapy
11. Influence of Health Beliefs on COVID-19 Vaccination among Individuals with Cancer and Other Comorbidities in Puerto Rico
    McClaren Rodríguez, Andrea Alexandra Lopez‐Cepero, Ana Patricia Ortiz-Martinez, Emma Fernández–Repollet, Cynthia M. Pérez · 2021 · Vaccines
12. Mental Health and Adherence to COVID-19 Protective Behaviors among Cancer Patients during the COVID-19 Pandemic: An International, Multinational Cross-Sectional Study
    Angelos P. Kassianos, Alexandros Georgiou, Maria Kyprianidou, Demetris Lamnisos, Jeļena Ļubenko, Giovambattista Presti, Valeria Squatrito, Marios Constantinou, Christiana Nicolaou, Savvas Papacostas et al. · 2021 · Cancers
13. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations
    Bülent Kantarcıoğlu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio A. Lievano, Mark A. Ligocki, Walter P Jeske, Cafer Adıgüzel, Grigoris Gerotziafas et al. · 2022 · Clinical and Applied Thrombosis/Hemostasis
14. Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases
    Carlos Martínez-Chinchilla, Lucía Vázquez-Montero, Natalia Palazón Carrión, Isabel Fernández-Román, José López-Barba, Luis de la Cruz‐Merino, Jesús Rodríguez‐Baño, Zaira Raquel Palacios-Baena · 2022 · Frontiers in Immunology
15. Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
    Anjing Chen, Wenguo Zhao, Xiaolong Li, Guangyu Sun, Zhaoyin Ma, Lingyu Peng, Zhongyang Shi, Xingang Li, Jie Yan · 2022 · Frontiers in Immunology
16. Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
    Helen Kakkassery, Esme Carpenter, Piers Patten, Sheeba Irshad · 2022 · Trends in Molecular Medicine
17. Impact of the COVID-19 pandemic on cancer care in Ireland – Perspectives from a COVID-19 and Cancer Working Group
    Séamus O’Reilly, Hailey Kathryn Carroll, Deirdre M. Murray, Louise Burke, Triona McCarthy, Robert A. O'Connor, Claire Kilty, Sonya Lynch, Jennifer Feighan, Maeve Cloherty et al. · 2023 · Journal of Cancer Policy
18. Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19
    Guilherme Nader Marta, Renata Colombo Bonadio, Odeli Nicole Encinas Sejas, Gabriel Watarai, Maria Cecília Mathias-Machado, Lorena Teixeira Frasson, Camila Motta Venchiarutti Moniz, Raquel Keiko de Luca Ito, Driele Peixoto, Camilla Oliveira Hoff et al. · 2021 · JCO Global Oncology
19. The Responses of Biobanks to COVID-19
    Marianne K. Henderson, Zisis Kozlakidis, Jajah Fachiroh, Beatrice Wiafe Addai, Xun Xu, Sameera Ezzat, Heidi E. Wagner, Márcia Maria Chiquitelli Marques, Birenda K. Yadav · 2020 · Biopreservation and Biobanking
20. Cancer Patients with COVID-19: A Retrospective Study of 51 Patients in the District of Piacenza, Northern Italy
    Luigi Cavanna, Chiara Citterio, Ilaria Toscani, Cosimo Franco, Andrea Magnacavallo, Serena Caprioli, Evelina Cattadori, Camilla Di Nunzio, Roberto Pane, Roberta Schiavo et al. · 2020 · Future Science OA
21. Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East
    Riad Omar El Fakih, Alfadil Haroon, Feras Abdulaziz Alfraih, Murtadha K. Al-Khabori, Mohsen Alzahrani, Ahmad Alhuraiji, Abdulaziz Hamadah, Naif I. AlJohani, Bader Alahmari, Mohammed Essa et al. · 2021 · Bone Marrow Transplantation
22. Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
    Josep‐María Ribera, Mireia Morgades, Rosa Coll, Pere Barba, José Luis López Lorenzo, Pau Montesinos, Maria Angeles Foncillas, Mónica Cabrero, Ignacio Alberto Gómez-Centurión, María-Dolores Morales et al. · 2021 · Clinical Lymphoma Myeloma & Leukemia
23. A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
    Jennifer G. Whisenant, Javier Baena, Alessio Cortellini, Li‐Ching Huang, Giuseppe Lo Russo, Luca Porcu, Selina K. Wong, Christine M. Bestvina, Matthew David Hellmann, Elisa Roca et al. · 2022 · Journal of Thoracic Oncology
24. Impact of the COVID-19 Pandemic on Treatment and Oncologic Outcomes for Cancer Patients in Romania
    Oana Gabriela Trifanescu, Laurentia Nicoleta Gales, Xenia Elena Bacinschi, Luiza Georgia Serbanescu, Mihai Géorgescu, Alexandra Roberta Sandu, Alexandru Michire, Rodica Maricela Anghel · 2022 · In Vivo
25. Outcomes of COVID-19 and risk factors in patients with cancer
    Manju Sengar, Girish Chinnaswamy, Priya Ranganathan, Apurva Ashok, Shilpushp Jagannath Bhosale, Sanjay Biswas, Pankaj Chaturvedi, Chetan Anil Dhamne, Jigeeshu Vasishtha Divatia, Karishma D’Sa et al. · 2022 · Nature Cancer
26. Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in Japan
    Makoto Hibino, Kiyoaki Uryu, Takayuki Takeda, Yusuke Kunimatsu, Shinsuke Shiotsu, Junji Uchino, Soichi Hirai, Tadaaki Yamada, Asuka Okada, Yoshikazu Hasegawa et al. · 2022 · Journal of Thoracic Oncology
27. Knowledge, Attitude, and Perception of Cancer Patients towards COVID-19 in Pakistan: A Cross-Sectional Study
    Saadullah Khattak, Muhammad Faheem, Bilawal Nawaz, Maqbool Khan, Nazeer Hussain Khan, Nadeem Ullah, Taj Ali Khan, Rahat Ullah Khan, Kashif Syed Haleem, Zhiguang Ren et al. · 2022 · International Journal of Environmental Research and Public Health
28. Accelerated ageing is associated with increased COVID-19 severity and differences across ethnic groups may exist
    Joshua Reeves, Jaspal Singh Kooner, Weihua Zhang · 2022 · Frontiers in Public Health
29. Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
    Paolo Pedrazzoli, Angioletta Lasagna, Irene Cassaniti, Antonio Piralla, Andrea Squeri, Raffaele Bruno, Paolo Sacchi, Fausto Baldanti, Massimo Di Maïo, Giordano Domenico Beretta et al. · 2023 · ESMO Open
30. A DFT study of sulforaphane adsorption on the group III nitrides (B12N12, Al12N12 and Ga12N12) nanocages
    ShiQuan Wu, Li Li, Qi-Qi Liang, Hua-Xu Gao, Tianyu Tang, Yan-Lin Tang · 2023 · Journal of Biomolecular Structure and Dynamics
31. Cancer Care Management During the COVID-19 Pandemic
    Ameneh Jafari, Mostafa Rezaei–Tavirani, Samira Karami, Mohsen Yazdani, Hakimeh Zali, Zahra Jafari · 2020 · Risk Management and Healthcare Policy
32. Minority Enrollment to Clinical Trials: Road to Increased Access
    Julie Marie Vose · 2021 · ONCOLOGY
33. SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic
    Biniam Kidane, Jonathan David Spicer, Julian Oliver Kim, Pierre Fiset, Bassam Abdulkarim, Richard A. Malthaner, David A. Palma · 2020 · Frontiers in Oncology
34. Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure
    Fatih Mehmet Uckun, James Carlson, Cemal Orhan, Joy Powell, Natalie M. Pizzimenti, Hendrik van Wyk, İbrahim H. Özercan, Michael Volk, Kazım Şahin · 2020 · Frontiers in Pharmacology
35. COVID-19 Associated Mortality and Cardiovascular Disease Outcomes Among U.S. Women Veterans
    Shirling X. Tsai, Hang Nguyen, Ramin Ebrahimi, Monica R. Barbosa, Bala Ramanan, Daniel F. Heitjan, Jeffrey L. Hastings, John Gregory Modrall, Haekyung Jeon‐Slaughter · 2020 · Scientific Reports
36. Changes in Cancer Management due to COVID-19 Illness in Patients with Cancer in Northern California
    Julie Tsu-Yu Wu, Daniel Hyuck-Min Kwon, Michael J. Glover, A. Solomon Henry, Douglas Wood, Daniel L. Rubin, Vadim S. Koshkin, Lidia Schapira, Sumit Anil Shah · 2020 · JCO Oncology Practice
37. Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer
    Nicole M. Kuderer, Joshua Aiden Hill, Paul A. Carpenter, Gary H. Lyman · 2021 · Cancer Investigation
38. Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19
    Nancy A Dreyer, Natalia Petruski‐Ivleva, Lisa Albert, Damir Mohamed, Emma Brinkley, Matthew W. Reynolds, Stephen Toovey · 2021 · International Journal of General Medicine
39. SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors
    Flora Zagouri, Evangelos Terpos, Oraianthi Fiste, Michalis Liontos, Αlexandros Briasoulis, Ioanna Katsiana, Efi Skafida, Christos Markellos, Elena Kunadis, Αngeliki Andrikopoulou et al. · 2021 · The Breast
40. Management of Patients With Glucocorticoid-Related Diseases and COVID-19
    Irina Oana Chifu, Mario Detomas, Ulrich Dischinger, Otilia Kimpel, Felix Megerle, Stefanie Hahner, Martin Faßnacht, Barbara Altieri · 2021 · Frontiers in Endocrinology
41. Challenges faced in the cancer diagnosis and management—COVID-19 pandemic and beyond—Lessons for future
    Durre Aden, Sufian Zaheer, Swati Raj · 2022 · Heliyon
42. Impact of COVID-19 on Cancer-Related Care in the United States: An Overview
    Iktej Singh Jabbal, Saad Sabbagh, Barbara Geraldine Dominguez, Mira Itani, Mohamed Mohanna, Thomas A. Samuel, Zeina A. Nahleh · 2023 · Current Oncology
43. A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)
    Thomas Starkey, Maria C. Ionescu, Michael Tilby, Martin Little, Emma Burke, Matthew W. Fittall, Sam Khan, Justin K. H. Liu, James Robert Platt, Rosie Mew et al. · 2023 · Scientific Reports
44. Cancer Imaging and Patient Care during the COVID-19 Pandemic
    Adeline N. Boettcher, Dima A. Hammoud, Jason B. Weinberg, Prachi Agarwal, Mishal Mendiratta‐Lala, Gary D. Luker · 2020 · Radiology Imaging Cancer
45. The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying—the head and neck cancer model
    Leandro Luongo Matos, Carlos Henrique Quartucci Forster, Gustavo Nader Marta, Gilberto de Castro, John Andrew Ridge, D. Hirata, Adalberto Miranda‐Filho, Ali Hosny, Álvaro Sanabria, Vincent Grégoire et al. · 2021 · Cancer Causes & Control
46. Clinical features and outcomes of COVID ‐19 in patients with solid tumors: Turkish National Registry Data
    Nuriye Özdemir, Ömer Dızdar, Ozan Yazıcı, Sercan Aksoy, Didem Şener Dede, Burçin Budakoğlu, Gökhan Metan, Alpaslan Alp, Işıl İrem Budakoğlu, Berna Çakmak Öksüzoğlu et al. · 2020 · International Journal of Cancer
47. Cocooning against COVID‐19: The argument for vaccinating caregivers of patients with cancer
    Maresa C. Woodfield, Steven A. Pergam, Parth D. Shah · 2021 · Cancer
48. Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
    Pierre‐Etienne Heudel, Bertrand Favier, Marie-Laure Solodky, Souad Assaad, Natacha Chaumard, Olivier Trédan, Thomas Bachelot, Isabelle Laure Ray-Coquard, Bruno Russias, Marie-Line Fournier et al. · 2022 · European Journal of Cancer
49. The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review
    Verma, Ridhi, Kilgour, Heather M., Haase, Kristen R. · 2022 · Current Oncology
50. COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes
    Raphaël Lattenist, Halil Yıldız, Julien De Greef, Sarah Bailly, Jean Cyr Yombi · 2020 · Indian Journal of Hematology and Blood Transfusion
51. Influenza and pneumonia-attributed deaths among cancer patients in the United States; a population-based study
    Omar Mohammed Abdel-Rahman · 2020 · Expert Review of Respiratory Medicine
52. Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience
    Christopher C.T. Sng, Yien Ning Sophia Wong, Anjui Wu, Diego Ottaviani, Neha Chopra, Myria Galazi, Sarah Benafif, Gehan Soosaipillai, Rebecca R. Roylance, Alvin J. X. Lee et al. · 2020 · Frontiers in Oncology
53. Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic
    Manit K. Gundavda, Kaival K. Gundavda · 2020 · SN Comprehensive Clinical Medicine
54. Excess Mortality in a Nationwide Cohort of Cancer Patients during the Initial Phase of the COVID-19 Pandemic in Belgium
    Geert Silversmit, Freija Verdoodt, Nancy Van Damme, Harlinde De Schutter, Liesbet J. Van Eycken · 2021 · Cancer Epidemiology Biomarkers & Prevention
55. COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital
    Katharina Pomej, Bernhard Scheiner, Lukas Hartl, Lorenz Balcar, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Christian Müller, Michael A Trauner, Matthias Pinter · 2021 · PLoS ONE
56. The effects of COVID-19 pandemic on emergency anterior abdominal wall hernia surgery: is it safe to postpone elective hernia surgery in the pandemic?
    Ümit Turan, Ahmet Barış Dirim · 2021 · European Journal of Trauma and Emergency Surgery
57. Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study
    Gowri Satyanarayana, Kyle T. Enriquez, Tianyi Sun, Elizabeth J. Klein, Maheen Z. Abidi, Shailesh Advani, Joy A. Awosika, Ziad Bakouny, Babar Bashir, Stephanie A Berg et al. · 2022 · Open Forum Infectious Diseases
58. SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021)
    Isabel Echavarría, Jorge Galindo, Jesus Corral, María Pilar Diz-Taín, Fernando Henao, Vega Iranzo, Xabier Mielgo-Rubio, Teresa Quintanar, Carlos Rivas Corredor, Pedro Pérez Segura · 2022 · Clinical & Translational Oncology
59. Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
    Sherin Juliet Rouhani, Jovian Yu, Daniel J. Olson, Yuanyuan Zha, Apameh Pezeshk, Alexandra Cabanov, Athalia Rachel Pyzer, Jonathan Trujillo, Benjamin Avi Derman, Peter H. O’Donnell et al. · 2022 · Journal for ImmunoTherapy of Cancer
60. Evaluating the impact of COVID ‐19 on cancer declarations in Quebec, Canada
    Agnihotram V. Ramanakumar, Bourassa Annie, Frederic Lamonde, Bertrand Christine, Rouleau Cathy, Jean Latreille · 2022 · Cancer Medicine
61. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship
    ISSAM I. RAAD, Ray Y Hachem, Masayuki Nigo, Tarcila Santos Datoguia, Hiba Dagher, Ying Jiang, Vivek Subbiah, Bilal Karim Siddiqui, Arnaud Bayle, Robert A. Somer et al. · 2023 · eLife
62. Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications
    A. H. M. Safayet Ullah Prodhan, Dewan Zubaer Islam, Shahad Saif Khandker, Mohd. Raeed Jamiruddin, Adnan Abdullah, Brian Godman, Sylvia Adisa Opanga, Santosh Kumar, Paras Sharma, Nihad Adnan et al. · 2023 · Breast Cancer Targets and Therapy
63. The Influence of COVID-19 on New Lung Cancer Diagnoses, by Stage and Treatment, in Northern Italy
    Lucìa Mangone, Francesco Marinelli, Isabella Bisceglia, Angelina Filice, Lisa De Leonibus, Cristian Rapicetta, Massimiliano Paci · 2023 · Biology
64. Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario
    Valentina Bertaglia, Anna Maria Morelli, Cinzia Solinas, Marco Maria Aiello, Silvia Manunta, Nerina Denaro, Marco Tampellini, Mario Scartozzi, Silvia Novello · 2023 · Critical Reviews in Oncology/Hematology
65. Investigating the drug carrying ability of Al and Ga doped B12N12 nanocages for 5-fluorouracil based on DFT
    ShiQuan Wu, Li Li, Qi-Qi Liang, Hua-Xu Gao, De‐Yuan Hu, Tianyu Tang, Yan-Lin Tang · 2023 · New Journal of Chemistry
66. Protecting vulnerable patient populations from climate hazards: the role of the nation’s cancer centers
    Zelde Espinel, James M. Shultz, Vanina Pavia Aubry, Omar Munoz Abraham, Qinjin Fan, Tracy E. Crane, Liora Sahar, Letícia Nogueira · 2023 · JNCI Journal of the National Cancer Institute
67. COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study
    Valerie Elizabeth Crolley, Daire Hanna, Nalinie Joharatnam‐Hogan, Neha Chopra, Ekin Bamac, Meera Desai, Yuk-Chun Lam, Sabiq Dipro, Ruhi Kanani, Jack Benson et al. · 2020 · Therapeutic Advances in Medical Oncology
68. Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study
    Naomi Alpert, Joseph L. Rapp, Bridget Kelly Marcellino, Wil Lieberman‐Cribbin, Raja Michael Flores, Emanuela Taioli · 2020 · JNCI Cancer Spectrum
69. Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers
    Chaobin He, Xin Hua, Shuxin Sun, Shaolong Li, Jun Wang, Xin Huang · 2021 · Journal of Inflammation Research
70. Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia: A Cost-Effectiveness Analysis
    Edward Li, Dylan J. Mezzio, David Campbell, Kim Campbell, Gary H. Lyman · 2021 · JCO Oncology Practice
71. Cannabis Use among Cancer Survivors amid the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study
    Marlene Camacho‐Rivera, Jessica Y. Islam, Diane L. Rodriguez, Denise Christina Vidot · 2021 · Cancers
72. Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany
    Till Kaltofen, Friederike Hagemann, Nadia Harbeck, Rachel Wuerstlein, Bernd Peter Kost, Alexander Burges, Sven Mahner, Fabian Trillsch · 2021 · Archives of Gynecology and Obstetrics
73. COVID-19 and haematological malignancy: navigating a narrow strait
    Samuel M. Rubinstein, Jeremy Lyle Warner · 2020 · The Lancet Haematology
74. Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome
    Rebecca J. Lee, Oskar Wysocki, Talvinder Bhogal, Rohan Shotton, Ann Tivey, Angelos Angelakas, T. Aung, Kathryn Banfill, Mark A Baxter, H. Boyce et al. · 2021 · ESMO Open
75. Impact of the SARS-COV-2 outbreak on epidemiology and management of major traumain France: a registry-based study (the COVITRAUMA study)
    and the Traumabase Group, Jean-Denis Moyer, Arthur James, Clément Gakuba, Mathieu Boutonnet, Emeline Angles, Emmanuel Rozenberg, Jean Bardon, Thomas Clavier, Vincent Legros et al. · 2021 · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine
76. Covid-19 related oncologist’s concerns about breast cancer treatment delays and physician well-being (the CROWN study)
    Katharine A. Yao, Deanna J. Attai, Richard J. Bleicher, Kristine Marie Kuchta, Meena S. Moran, Judy Caroline Boughey, Lee Gravatt Wilke, Jill R. Dietz, Randy E. Stevens, Catherine E. Pesce et al. · 2021 · Breast Cancer Research and Treatment
77. A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis
    María Sereno, Ana María Jimenez-Gordo, Javier Baena, Carlos Aguado, Xabier Mielgo-Rubio, A. Pertejo, Rosa Álvarez-Álvarez, Ana Sánchez, José Luis López, Raquel Molina et al. · 2021 · Cancers
78. ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
    Filippos K. Triposkiadis, Andrew V. Xanthopoulos, Grigorios Giamouzis, Konstantinos Dean Boudoulas, Randall C. Starling, John S. Skoularigis, Harisios K Boudoulas, Efstathios K. Iliodromitis · 2021 · Journal of Clinical Medicine
79. Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040
    Qingwei Luo, Jie‐Bin Lew, Julia Steinberg, Joachim Worthington, Xue Qin Yu, Michael Caruana, Isabelle Soerjomataram, Freddie Bray, Sheena Lawrance, Maria Arcorace et al. · 2022 · Scientific Reports
80. SARS-Cov-2 infection in cancer patients, susceptibility, outcome and care
    Mojgan Alaeddini, Shahroo Etemad‐Moghadam · 2022 · The American Journal of the Medical Sciences
81. Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
    Daniele Zama, F. Baccelli, A. Colombini, Amalia Contino, E. Calore, M. Petris, Linda Meneghello, Federico Mercolini, Andrea Lo Vecchio, Shana Montalto et al. · 2022 · Annals of Hematology
82. Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic
    David J. H. Bian, Siham Sabri, Bassam Abdulkarim · 2022 · Cancers
83. The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer over a 2-Year Period at a Canadian Academic Center
    Goulnar Kasymjanova, Angelo Rizzolo, Carmela Pepe, Jennifer Elisabeth Friedmann, David I. Small, Jonathan David Spicer, Magali Lecavalier‐Barsoum, Khalil Sultanem, Hangjun Wang, Alan Spatz et al. · 2022 · Current Oncology
84. SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants
    David B. Reeg, Maike Hofmann, Christoph Neumann‐Haefelin, Robert Thimme, Hendrik Luxenburger · 2023 · Pathogens
85. Assessment of Changes in Cancer Treatment During the First Year of the COVID-19 Pandemic in the US
    Letícia Nogueira, Elizabeth J. Schafer, Qinjin Fan, Nikita Sandeep Wagle, Jingxuan Zhao, Kewei Sylvia Shi, Xuesong Han, Ahmedin Jemal, K. Robin Yabroff · 2023 · JAMA Oncology
86. Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data
    Xiangyi Kong, Yihang Qi, Junjie Huang, Yang William Zhao, Yongle Zhan, Xuzhen Qin, Zhihong Qi, Adejare Jay Atanda, Lei Zhang, Yi Fang et al. · 2021 · Cancer Letters
87. Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
    Mónica Tang, Benjamin J. Daniels, Maria Aslam, Andrea L. Schaffer, Sallie‐Anne Pearson · 2021 · The Lancet Regional Health - Western Pacific
88. Network propagation-based prioritization of long tail genes in 17 cancer types
    Hussein Mohsen, Vignesh Gunasekharan, Tao Qing, Montrell Seay, Yulia V. Surovtseva, Sahand N. Negahban, Zoltán Szállási, Lajos Pusztai, Mark Gerstein · 2021 · Genome biology
89. Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients
    Weitao Zhuang, Jingyu Zhang, Peijian Wei, Zihua Lan, Rixin Chen, Cheng Chu Zeng, Qiuling Shi, Guibin Qiao · 2021 · Human Vaccines & Immunotherapeutics
90. COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic
    Olivia D. Lara, Maria J. Smith, Yuyan Wang, Roisin Eilish O'Cearbhaill, Stephanie V. Blank, Valentin Kolev, Caitlin E. Carr, Anne T. Knisely, Jennifer McEachron, Lisa R. Gabor et al. · 2021 · Gynecologic Oncology
91. Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection
    MUHAMMAD BILAL LATIF, Sudhanshu Shukla, Perla M. Del Río Estrada, Susan Pereira Ribeiro, Rafick‐Pierre Sékaly, Ashish Sharma · 2021 · Translational research
92. The Intriguing Thyroid Hormones–Lung Cancer Association as Exemplification of the Thyroid Hormones–Cancer Association: Three Decades of Evolving Research
    Maria V. Deligiorgi, Dimitrios T. Trafalis · 2021 · International Journal of Molecular Sciences
93. COVID-19 Pneumonia and Lung Cancer: A Challenge for the Radiologist Review of the Main Radiological Features, Differential Diagnosis and Overlapping Pathologies
    Alessia Guarnera, Elena Santini, Pierfrancesco Podda · 2022 · Tomography
94. Cancer and COVID-19
    Dimitrios Moris, Diamantis I. Tsilimigras, Dimitriοs Schizas · 2020 · The Lancet
95. Molecular Review Covid19 from the Pathogenesis and Transmission Aspect
    Fery Setiawan, Heni Puspitasari, Jenny Sunariani, Ahmad Yudianto · 2020 · JURNAL KESEHATAN LINGKUNGAN
96. Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic
    Daniel J. Boffa, Benjamin L. Judson, Kevin G. Billingsley, Erin Del Rossi, Kasey Hindinger, Samantha L. Walters, Theresa Ermer, Elena Ratner, Marci R. Mitchell, Maxwell S. H. Laurans et al. · 2020 · Annals of Surgery
97. Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study
    Valentina Guarneri, Franco Bassan, Vittorina Zagonel, Michele Stanislaw Milella, Marta Zaninelli, Anna Maria Cattelan, Andrea Vianello, Stefania Gori, Giuseppe Aprile, Giuseppe Azzarello et al. · 2021 · European Journal of Cancer
98. The Impact of Comorbidities on the Outcomes of Egyptian COVID-19 Patients: A Follow-Up Study
    Reda M. Albadawy, Bismeen A. Jadoon, Mysara M. Mogahed, Mohamed Mostafa Ibrahim, Tarek Samy Essawy, Ahmed M. A. Amin, Marwa Salah El-Dien Abd-Elraouf, Mona Ahmed Elawady · 2021 · Journal of Environmental and Public Health
99. COVID-19 in cancer patients
    Suranjith Luke Seneviratne, Widuranga Wijerathne, Pamodh Chanuka Yasawardene, Buddhika Somawardana · 2022 · Transactions of the Royal Society of Tropical Medicine and Hygiene
100. The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants
     Qing Wu, Shuimei Luo, Xianhe Xie · 2022 · BMC Cancer